Biofrontera Inc   (BFRI)
Other Ticker:  


Biofrontera Inc

BFRI's Financial Statements and Analysis

Biofrontera Inc narrowed III. Quarter net loss per share of $-0.11 compare to net loss per share of $-2.00 recorded in the same quarter a year ago a decrease compare to $-0.05 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ -0.11 $  6 Mill
$+1.89     $+1M     +27.07 %

Biofrontera Inc 's Revenue rose by 27.07 % in III. Quarter (Sep 30 2022) year on year, to $6 million and declined by -43.97 % sequentially.

Biofrontera Inc is Expected to report next financial results on April 07, 2023.

More on BFRI's Income Statement

Biofrontera Inc 's in III. Quarter recorded net loss of $-2.566 million, an improvement compare to net loss of $-16.012 million in III. Quarter a year ago.

Sequentially net loss advanced

More on BFRI's Growth

Inventories grew by 122.23 % to $12 million from III. Quarter a year ago, sequentially inventories rose by 37.23 %. In III. Quarter company's net cash and cash equivalents decreased by $-4 million, capital expenditures grew by -50.00%, to $0 millions compare to same quarter a year ago and rose by -96.77% from II. Quarter (Jun 30 2022).

More on BFRI's Cash flow Statement

Biofrontera Inc does not pay out common stock dividend.

In trailing twelve-month period Biofrontera Inc payed $ -1.27 cash per share, on a free-cash flow basis .